Strategy and Core Competences

  • 2010

    8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

    Read More >

  • Meet us

    The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

    Read More >

Strategy and Core Competences

Strategy
Zealand Pharma’s goal is to continue to use its clinical experience to identify indications of significant unmet clinical need and commercial potential. The Company applies its strategy of utilizing its proprietary SIP®-technology, augmented by the Company’s peptide know-how, to optimize and develop well-understood peptides targeted at well-known mechanisms.
Zealand Pharma’s strategy can be summarized as follows:

  • Peptide innovation focused on validated mechanisms, significant unmet clinical needs and commercial potential. 
  • Development of patent-protected, peptide products with improved therapeutic qualities, i.e. efficacy and safety. 
  • Advance the development of innovative peptide product candidates via partnering. 

Core Competences
Zealand Pharma has a number of core competences that drive the implementation of its strategy including:

  • Expertise in identifying areas of significant unmet clinical need and commercial potential
  • Expertise in optimizing and developing potentially valuable peptides
  • Ability to secure partnerships with industry leaders
  • Operating platform emphasizing creativity, productivity and speed of drug development

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.